VERA (STOCKS)
Vera Therapeutics, Inc. Class A Common Stock
$43.590000
-1.450000 (-3.22%)
Prev close: $45.040000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Marshall W. Fordyce
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,116.82M
- Employees
- 224
- P/E (TTM)
- -9.37
- P/B (TTM)
- 5.31
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
11
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.39 | $-1.31 | -0.0827 | -6.33% |
|
Sep 2025 (Q3)
|
$-1.26 | $-1.16 | -0.1015 | -8.76% |
|
Jun 2025 (Q2)
|
$-1.20 | $-0.84 | -0.3619 | -43.18% |
|
Mar 2025 (Q1)
|
$-0.81 | $-0.75 | -0.0603 | -8.04% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $15.86M |
| Operating Expenses | $315.47M |
| Research and Development | $215.26M |
| Other Operating Expenses | $100.22M |
| Operating Income/Loss | -$315.47M |
| Income/Loss From Continuing Operations After Tax | -$299.62M |
| Income/Loss From Continuing Operations Before Tax | -$299.61M |
| Income Tax Expense/Benefit | $1.00K |
| Net Income/Loss | -$299.62M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$299.62M |
| Net Income/Loss Available To Common Stockholders, Basic | -$299.62M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.66 |
| Diluted Earnings Per Share | -$4.66 |
| Basic Average Shares | 64,233,814 |
| Diluted Average Shares | 64,233,814 |
| Assets | $734.73M |
| Current Assets | $728.88M |
| Noncurrent Assets | $5.85M |
| Fixed Assets | $1.37M |
| Other Non-current Assets | $4.48M |
| Liabilities | $130.21M |
| Current Liabilities | $53.46M |
| Accounts Payable | $21.90M |
| Wages | $18.70M |
| Other Current Liabilities | $12.86M |
| Noncurrent Liabilities | $76.76M |
| Long-term Debt | $74.84M |
| Other Non-current Liabilities | $1.92M |
| Equity | $604.52M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $604.52M |
| Liabilities And Equity | $734.73M |
| Net Cash Flow From Operating Activities | -$241.10M |
| Net Cash Flow From Operating Activities, Continuing | -$241.10M |
| Net Cash Flow From Investing Activities | $194.29M |
| Net Cash Flow From Investing Activities, Continuing | $194.29M |
| Net Cash Flow From Financing Activities | $308.90M |
| Net Cash Flow From Financing Activities, Continuing | $308.90M |
| Net Cash Flow | $262.08M |
| Net Cash Flow, Continuing | $262.08M |
| Comprehensive Income/Loss | -$299.22M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$299.22M |
| Other Comprehensive Income/Loss | -$299.22M |